SHPH Stock: Insider & Congress Trades

Smart money at a glance

Filings to Nov 14, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

No analyst estimates.

Questions about SHPH filings

Are insiders buying or selling Shuttle Pharmaceuticals Inc (SHPH) stock?

Neither. Shuttle Pharmaceuticals Inc (SHPH) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded SHPH recently?

None. No member of Congress disclosed a SHPH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this SHPH smart-money data?

This summary uses filings available on Nov 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

Smart money on SHPH

Lean short1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
Lean short1 buy · 2 sales
Form 4 filings, open market.
Congress
No recent politician filings found
Funds
No recent fund filings found
Influencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about SHPH filings

Are insiders buying or selling Shuttle Pharmaceuticals Inc (SHPH) stock?

Neither. Shuttle Pharmaceuticals Inc (SHPH) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded SHPH recently?

None. No member of Congress disclosed a SHPH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this SHPH smart-money data?

Insiders

What insiders are doing

6 trades · 6 mo

Bought$154KSold$505K

Buys (1)

HF
Hrt Financial Lp
10% · Jul 13
$30K
bought

Sells (2)

HF
Hrt Financial Lp
10% · Jul 15
$373K
sold
Signals like this: n=8127, 50% finished lower at D15, median -0.1% vs SPY +0.6%
HF
Hrt Financial Lp
10% · Jul 9
$100K
sold

2 more trades

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 2 trades

Unlock everything for $29/month

Unlock for $29/month

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K Every filing

The latest quarter is still settling.

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 12, 2026	Not on file	No estimate	Not on file	Not on file
Jun 30, 2026Reported Sep 24, 2026	-$3.84Reported	No estimate	Not on file	Not on file
Mar 31, 2026Reported Apr 1, 2026	-$4.28Reported	No estimate	Not on file	Not on file
Dec 31, 2025Reported Dec 31, 2025	-$12.92Reported	No estimate	Not on file	Not on file
Sep 30, 2025Reported Nov 13, 2025	-$1.05Reported	No estimate	Not on file	Not on file
Jun 30, 2025Reported Aug 12, 2025	-$3.29Reported	No estimate	Not on file	Not on file
Mar 31, 2025Reported May 8, 2025	-$7.60Reported	No estimate	Not on file	Not on file
Dec 31, 2024Reported Mar 20, 2025	-$0.40Reported	No estimate	Not on file	Not on file

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $5.11
High: $5.34
Low: $5.08
Prev close: $5.19
52-wk high: $27.30
52-wk low: $2.58
Mkt cap: $25.0M
ROE: -90.0%
Beta: 1.02
P/B: 1.3x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $25M

Valuation

P/B1.30

Quality

Operating margin0.0%
ROE-90.0%
ROA-49.5%

Growth

Beta1.02

Technicals

Price structure

This stock is trending upward.

Trend

Constructive

75 / 100

RSI 14

60balanced

20D volatility

80%annualized

52-week range

$5.34

$2.58$27.30

20D support

$3.30recent floor

20D resistance

$5.68recent ceiling

Returns

5D +3.7%20D +3.1%60D +30.2%

Price vs moving averages

SMA20 +4.6%SMA50 +21.2%SMA200 -18.1%

Volume pace

0.63xvs prior 20D

Smart money at a glance

Filings to Nov 14, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

No analyst estimates.

Questions about SHPH filings

Are insiders buying or selling Shuttle Pharmaceuticals Inc (SHPH) stock?

Neither. Shuttle Pharmaceuticals Inc (SHPH) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded SHPH recently?

None. No member of Congress disclosed a SHPH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this SHPH smart-money data?

Smart money on SHPH

Lean short1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
Lean short1 buy · 2 sales
Form 4 filings, open market.
Congress
No recent politician filings found
Funds
No recent fund filings found
Influencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about SHPH filings

Are insiders buying or selling Shuttle Pharmaceuticals Inc (SHPH) stock?

Neither. Shuttle Pharmaceuticals Inc (SHPH) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded SHPH recently?

None. No member of Congress disclosed a SHPH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this SHPH smart-money data?

Insiders

What insiders are doing

6 trades · 6 mo

Bought$154KSold$505K

Buys (1)

HF
Hrt Financial Lp
10% · Jul 13
$30K
bought

Sells (2)

HF
Hrt Financial Lp
10% · Jul 15
$373K
sold
Signals like this: n=8127, 50% finished lower at D15, median -0.1% vs SPY +0.6%
HF
Hrt Financial Lp
10% · Jul 9
$100K
sold

2 more trades

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 2 trades

Unlock everything for $29/month

Unlock for $29/month

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K Every filing

The latest quarter is still settling.

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 12, 2026	Not on file	No estimate	Not on file	Not on file
Jun 30, 2026Reported Sep 24, 2026	-$3.84Reported	No estimate	Not on file	Not on file
Mar 31, 2026Reported Apr 1, 2026	-$4.28Reported	No estimate	Not on file	Not on file
Dec 31, 2025Reported Dec 31, 2025	-$12.92Reported	No estimate	Not on file	Not on file
Sep 30, 2025Reported Nov 13, 2025	-$1.05Reported	No estimate	Not on file	Not on file
Jun 30, 2025Reported Aug 12, 2025	-$3.29Reported	No estimate	Not on file	Not on file
Mar 31, 2025Reported May 8, 2025	-$7.60Reported	No estimate	Not on file	Not on file
Dec 31, 2024Reported Mar 20, 2025	-$0.40Reported	No estimate	Not on file	Not on file

Open: $5.11
High: $5.34
Low: $5.08
Prev close: $5.19
52-wk high: $27.30
52-wk low: $2.58
Mkt cap: $25.0M
ROE: -90.0%
Beta: 1.02
P/B: 1.3x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $25M

Valuation

P/B1.30

Quality

Operating margin0.0%
ROE-90.0%
ROA-49.5%

Growth

Beta1.02

Technicals

Price structure

This stock is trending upward.

Trend

Constructive

75 / 100

RSI 14

60balanced

20D volatility

80%annualized

52-week range

$5.34

$2.58$27.30

20D support

$3.30recent floor

20D resistance

$5.68recent ceiling

Returns

5D +3.7%20D +3.1%60D +30.2%

Price vs moving averages

SMA20 +4.6%SMA50 +21.2%SMA200 -18.1%

Volume pace

0.63xvs prior 20D

Shuttle Pharmaceuticals Inc

Smart money at a glance

What do analysts expect?

Questions about SHPH filings

Smart money on SHPH

Questions about SHPH filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Results versus expectations

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Shuttle Pharmaceuticals Inc

Smart money at a glance

What do analysts expect?

Questions about SHPH filings

Smart money on SHPH

Questions about SHPH filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Results versus expectations

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Shuttle Pharmaceuticals Inc

Overview

Questions about SHPH filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Shuttle Pharmaceuticals Inc

Overview

Questions about SHPH filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.